Abstract
This paper reviews the principal strategies for multicomponent determinations of pharmaceutical products and related compounds using flow-injection analysis (FIA). The relevancy of this topic in the pharmaceutical field and close areas such as clinical, food and biochemical analysis is pointed out. As an alternative to chromatographic and electrophoretic methods, multicomponent FIA is specially suitable for a rapid quantification of analytes and processing large sets of samples. The achievement of selective measurement conditions to carry out the quantification of each drug without interferences is commonly needed in multicomponent analysis. The main approaches for gaining selectivity are based on specific reagents, multi-way or fast-scanning detectors, serial and parallel multi-channel manifolds. Alternatively, chemometric methods for data analysis can be used when selectivity is not fully accomplished.
Keywords: Flow-injection analysis, Multicomponent analysis, Multichannel manifolds, Chemometrics, Active drugs
Current Pharmaceutical Analysis
Title: Multicomponent Determination of Drugs Using Flow-Injection Analysis
Volume: 2 Issue: 2
Author(s): Leah Hlabangana, Santiago Hernandez-Cassou and Javier Saurina
Affiliation:
Keywords: Flow-injection analysis, Multicomponent analysis, Multichannel manifolds, Chemometrics, Active drugs
Abstract: This paper reviews the principal strategies for multicomponent determinations of pharmaceutical products and related compounds using flow-injection analysis (FIA). The relevancy of this topic in the pharmaceutical field and close areas such as clinical, food and biochemical analysis is pointed out. As an alternative to chromatographic and electrophoretic methods, multicomponent FIA is specially suitable for a rapid quantification of analytes and processing large sets of samples. The achievement of selective measurement conditions to carry out the quantification of each drug without interferences is commonly needed in multicomponent analysis. The main approaches for gaining selectivity are based on specific reagents, multi-way or fast-scanning detectors, serial and parallel multi-channel manifolds. Alternatively, chemometric methods for data analysis can be used when selectivity is not fully accomplished.
Export Options
About this article
Cite this article as:
Hlabangana Leah, Hernandez-Cassou Santiago and Saurina Javier, Multicomponent Determination of Drugs Using Flow-Injection Analysis, Current Pharmaceutical Analysis 2006; 2 (2) . https://dx.doi.org/10.2174/157341206776819283
DOI https://dx.doi.org/10.2174/157341206776819283 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-Obesity Effect of Lactoferrin; Subgroup Analysis Excluding Subjects with Obese and/or Hyper-LDL Cholesterolemia
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Potential Roles of α-amylase in Alzheimer’s Disease: Biomarker and Drug Target
Current Neuropharmacology Cannabinoid Hyperemesis Syndrome
Current Drug Abuse Reviews Heat Shock Protein 90 Inhibitors as Therapeutic Agents
Recent Patents on Anti-Cancer Drug Discovery Neurobiology of Alzheimer’s Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions
Current Alzheimer Research Treatment of Diabetic Foot Ulcers
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Anticoagulant Therapy in Very Old Patients
Cardiovascular & Hematological Disorders-Drug Targets CART Peptides Regulate Psychostimulants and May be Endogenous Antidepressants
Current Neuropharmacology VEGF and Colon Cancer Growth Beyond Angiogenesis: Does VEGF Directly Mediate Colon Cancer Growth Via a Non-angiogenic Mechanism?
Current Pharmaceutical Design Emerging Therapeutic Targets for Metabolic Syndrome: Lessons from Animal Models
Endocrine, Metabolic & Immune Disorders - Drug Targets Taxation as Prevention and as a Treatment for Obesity: The Case of Sugar-Sweetened Beverages
Current Pharmaceutical Design Rheumatoid Arthritis and Cardiovascular Risk: Between Lights and Shadows
Current Rheumatology Reviews Antioxidant Properties of Melatonin and its Potential Action in Diseases
Current Topics in Medicinal Chemistry Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Tissue Protective and Anti-Fibrotic Actions of Suramin: New Uses of an Old Drug
Current Clinical Pharmacology Sugar-Borate Esters – Potential Chemical Agents in Prostate Cancer Chemoprevention
Anti-Cancer Agents in Medicinal Chemistry The Potential Role of Gut Microbiota in the Pathogenesis of Type 2 Diabetes Mellitus <i>via</i> Epigenetics and Inflammasome
Endocrine, Metabolic & Immune Disorders - Drug Targets Drug Delivery Across the Blood-Brain Barrier
Current Drug Delivery Enhancement Potential of Sucrose Laurate (L-1695) on Intestinal Absorption of Water-Soluble High Molecular Weight Compounds
Current Drug Delivery Selection and Evaluation of the Pediatric Epilepsy Surgical Candidates
Current Pediatric Reviews